Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Cutaneous T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology & Market Forecast to 2025 - Research and Markets

Research and Markets
Posted on: 02 Aug 17

The "Cutaneous T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology and Market Forecast - 2025" drug pipelines has been added to Research and Markets' offering.

The report provides comprehensive insights on the competitive landscape and market of Cutaneous T-Cell Lymphoma. The report covers an overview of the disease and market trends of the Cutaneous T-Cell Lymphoma data for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, UK) and Japan.

The report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Cutaneous T-Cell Lymphoma from 2017 to 2025 segmented by seven major markets. In addition, the report also includes the forecast of epidemiology of Cutaneous T-Cell Lymphoma till 2025. The report also covers market drivers, market barriers and unmet medical need. The competitive landscape of The report covers both pipeline and marketed portfolio of the indication. Cutaneous T-Cell Lymphoma pipeline provides information on the therapeutic drugs in development and comparative analysis at various stages covering clinical and pre-clinical & discovery stages, therapeutics assessment by Monotherapy/ Combination products and Molecule Type drug analysis.

It also provides in-depth analysis on the Phase III profile covering clinical trial studies, recent developments and SWOT Analysis. Cutaneous T-Cell Lymphoma is the rare type of Lymphoma which arises from the skin. It is characterized by the flat red patches on the skin. It can also affect the blood, lymph nodes and internal organs among patients with advanced stage. It is more common among males as compared to females. According to research, the Cutaneous T-Cell Lymphoma market size in 7MM is estimated to increase at a compound annual growth rate (CAGR) of 1.6% for the forecasted period 2013 - 2025. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by a team of industry experts.

Key Topics Covered:

1. Report Introduction

2. Cutaneous T-Cell Lymphoma

3. Epidemiology of Cutaneous T-Cell Lymphoma

4. Unmet Needs

5. Cutaneous T- Cell Lymphoma: Country-Wise Market Analysis

6. Market Drivers

7. Market Restraints

8. Appendix

9. Report Methodology

10. Consulting Services

11. Disclaimer

Companies Mentioned

  • Celgene Corporation
  • Seattle Genetics
  • Others...

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/b72qqg/cutaneous_tcell

View source version on businesswire.com: http://www.businesswire.com/news/home/20170802006013/en/

Business Wire
www.businesswire.com

Last updated on: 02/08/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.